They regained an average of 22 pounds in the first year with a projected estimate that they'd return to their original, pre-GLP-1 weight after 18 months
Over time, my weight drifted back up again, and it became pretty clear I was on the placebo. If he can get his insurance to cover Wegovy which he might be able to do, under the premise that it helps protect against heart disease he said he would leave the retatrutide study
Information on active UK trials can be found via the following resources: NIHR Be Part of Research (bepartofresearch.nihr.ac.uk) a UK-specific portal for finding clinical trials ISRCTN registry (isrctn.com) ClinicalTrials.gov (clinicaltrials.gov) Scientific References TripleHormone-Receptor Agonist Retatrutide for Obesity Phase 2 Trial
Although GLP-1s are generally safe for the liver, its important to check, especially before compounded meds Kidney function: to watch for stress on the kidneys, which can be exacerbated by GLP-1-induced dehydration and nausea, especially in older adults or those with preexisting conditions [1] Thyroid markers : to screen for an under-functioning thyroid gland, which can mimic or worsen weight gain
